Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020693 |
---|---|
Receipt number | R000023875 |
Scientific Title | Phase2 study of dose dense EC followed Nab-PTXas neoadjuvant chemotherapy for HER2-negative primary breast cancer |
Date of disclosure of the study information | 2016/04/01 |
Last modified on | 2019/07/26 05:21:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/01/21 22:35:57 | ||
2 | Update | 2018/01/21 15:56:19 | Last name of contact person Last name of contact person Name of primary person or sponsor Organization Organization |
|
3 | Update | 2018/09/10 14:19:52 | Recruitment status |
|
4 | Update | 2019/07/26 05:14:45 | 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Address Address Tel |
|
5 | Update | 2019/07/26 05:21:53 | Recruitment status Date of IRB Last follow-up date |